Moleculin Targets accelerated FDA approval of WP1732; Pursues Development for Ocular Tumors Jun 12, 2018
Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa Jun 6, 2018
Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2018 May 15, 2018
Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial May 3, 2018
Moleculin Announces New Data for Immuno-Stimulating Drug to be Presented at International Conference Apr 26, 2018
